Polycystic ovarian syndrome. Polycystic ovarian syndrome
Conditions
Interventions
Intervention 1: Intervention group:In the group receiving traditional medicine products,patient will use 4.5 g celery and anise powder (6 capsules divided into 3 meals ) for two weeks. If the menstru
Treatment - Drugs
Intervention group:In the group receiving traditional medicine products,patient will use 4.5 g celery and anise powder (6 capsules divided into 3 meals ) for two weeks. If the menstruation occurs at
Control group:In the group taking metformin,1500 mg metformin powder(6 capsules divided into 3 meals) for two weeks . In the menstruation days and the menstruation waited days,one metformin powder(50
Sponsors
Tabriz University of Medical Sciences-Deputy of Research and Technolog
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: patients satisfaction , Patients with PCOS that their main complaint is oligomenorrhea, age 40-18 years, no pregnancy, no abortion or within 6 weeks post partum; lack of breastfeeding, absence of any systemic diseases such as hyperinsulinemia and hyperandrogenism, diabetes, Cushing's syndrome, congenital adrenal hyperplasia, hyperprolactinemia, thyroid disorders, body mass index between 18 and 35 kg / m2; non-hormonal drugs in the last month, lack of uterine malignancies, ovarian and other malignancies;lack of Chronic liver disease and kidney failure, lack of headaches and epilepsy; willingness to participate in the study. Exclusion criteria: use of hormonal drugs during the study, the incidence of side effects, the need for other interventions and surgery, pregnancy during the study, patient request for exclusion.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Experience of menstural bleeding. Timepoint: Before intervention and 1,2, 3, 4 month after intervention. Method of measurement: Ask the patient and complete tracking form. | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of bleeding. Timepoint: Before intervention and 1,2,3, 4 month after intervention. Method of measurement: Ask the patient and complete tracking form.;Menstrual blood volume. Timepoint: Before intervention and1,2, 3, 4 month after intervention. Method of measurement: Pictorial Blood Loss Assessment Chart (PBAC).;Menstrual cycle length. Timepoint: Before intervention and1,2, 3, 4 month after intervention. Method of measurement: Ask the patient and complete tracking form.;Serum LH. Timepoint: Before intervention and 3 month after intervention. Method of measurement: Serum analysis by ELIZA.;LH/FSH proportion. Timepoint: Before intervention and 3 month after intervention. Method of measurement: Serum analysis by ELIZA.;Free Testosterone. Timepoint: Before intervention and 3 month after intervention. Method of measurement: Serum analysis by ELIZA.;Fasting Blood Suger(FBS). Timepoint: Before intervention and 3 month after intervention. Method of measurement: blood biochemistrical analysis.;Liver function test(AST,ALT). Timepoint: Before intervention and 3 month after intervention. Method of measurement: spectophotometry. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactArezoo Moini Jazani
School of Traditional Medicine-Tabriz University of Medical Sciences
Outcome results
None listed